- ASSOCIATE CLINICAL PROFESSOR Medicine
- ASSOCIATE CLINICAL PROFESSOR Geriatrics and Palliative Medicine
O'Brien TR, Blattner WA, Waters D, Seremetis S. Serum HIV-1 RNA Levels and Time to Development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996; 276(2): 105-110.
Abraham C, Seremetis S. Breast Health Midlife: Guidelines for Screening and Patient Evaluation. Geriatrics 1997; 52(6): 58-66.
Schwartz JD, Aledort L, Seremetis S. Liver failure and mortality in HIV positive hemophiliacs. Haemophilia 1997; 3: 24-30.
Seremetis S. Principles of Managing Haemophiliac Bleeding. In: Forbes CD, Madhok R, Aledort L, editors. Textbook of Hemophilia. London, Chapman and Hall; 1997. pp165.
Seremetis S, Lusher JM, Abildgaard CF, Kasper CK, Allred R, Hurst D, Kogenate Study Group . Human Recombinant DNA-Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A: Conclusions of a Five-Year Study of Home Therapy. Haemophilia 1999; 5(1): 9-16.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Seremetis is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.